Homocysteine is Linked to Macular Edema in Type 2 Diabetes

Reference

• Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al.; China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090–1101
   PubMed Web of Science ®Google Scholar
• Chen E, Looman M, Laouri M, Gallagher M, Van Nuys K, Lakdawalla D, et al. Burden of illness of diabetic macular edema: literature review. Curr Med Res Opin 2010;26:1587–1597
   PubMed Web of Science ®Google Scholar
• Seddon JM, Gensler G, Klein ML, Milton RC. C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration. Nutrition 2006; 22:441–443
   PubMedGoogle Scholar
• Starkebaum G, Harlan JM. Endothelial cell injury due to copper-oxidized hydrogen peroxide generation from homocysteine. Clin Invest 1986;77:1370–1376
   Google Scholar
• Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, et al. Adverse vascular effects of homocysteine are modulated by endothelial-derived relaxing factor and related oxides of nitrogen. Clin Invest 1993;91:308–318
   Google Scholar
• Abdella NA, Mojiminiyi OA, Akanji AO, Moussa MA. Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus. Acta Diabetol 2002;39:183–190
   PubMedGoogle Scholar
• Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001;73:613–621
   PubMed Web of Science ®Google Scholar
• Chico A, Perez A, Cordoba A, Arcelus R, Carreras G, de Leiva A, et al. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 1998;41:684–693
   PubMed Web of Science ®Google Scholar
• Storch KJ, Wagner DA, Young VR. Methionine kinetics in adult men: effects of dietary betaine on L-[2H3-methyl-1-13C]methionine. Am J Clin Nutr 1991;54:386–934
   PubMedGoogle Scholar
• Baines M, Kredan MB, Usher J, Davison A, Higgins G, Taylor W, et al. The association of homocysteine and its determinants: MTHFR genotype, folate, vitamin B12 and vitamin B6 with bone mineral density in postmenopausal British women. Bone 2007;40:730–736
   PubMed Web of Science ®Google Scholar
• Ganji V, Kafai MR. Demographic, lifestyle, and health characteristics and serum B vitamin status are determinants of plasma total homocysteine concentration in the post-folic acid fortification period, 1999-2004. J Nut 2009;139:345–352
   PubMed Web of Science ®Google Scholar
• Elias AN, Eng S. Homocysteine concentrations in patients with diabetes mellitus–relationship to microvascular and macrovascular disease. Diabetes Obes Metab 2005;7:117–121
   PubMed Web of Science ®Google Scholar
• Aydin E, Demir HD, Ozyurt H, Etikan I. Association of plasma homocysteine and maculopathy in type 2 diabetes mellitus. Eur J Ophthalmol 2008;18:226–232
   PubMed Web of Science ®Google Scholar
• Klein BE, Knudtson MD, Tsai MY, Klein R. The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 2009;127:1175–1182
   PubMed Web of Science ®Google Scholar
• WHO: World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva: World Health Org, 2006
   Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for Diabetic Maculopathy. Arch Ophthalmol 1985;103:1796–1806
   PubMed Web of Science ®Google Scholar
• Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677–1682
   Google Scholar
• Vivian F, Evan MB, Lawrence B, Kenneth C, Marjorie LC, Hertzel CG, et al. Summary of revisions for the 2006 Clinical practice recommendations. Diabetes Care 2006;29:S3
   Google Scholar
• Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004;50:1482–1483
   PubMedGoogle Scholar
• Hao L, Ma J, Zhu J, Stampfer MJ, Tian Y, Willett WC, et al. Vitamin B-12 deficiency is prevalent in 35- to 64-year-old Chinese adults. J Nutr 2007;137:1278–1285
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Eng J Med 2008;359:1577–1589
   PubMed Web of Science ®Google Scholar
• Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 2009;54:1–32
   PubMed Web of Science ®Google Scholar
• Liazos E, Broadbent DM, Beare N, Kumar N. Spontaneous resolution of diabetic macular oedema after discontinuation of thiazolidenediones. Diabet Med 2008;25:860–862
   PubMed Web of Science ®Google Scholar
• Jenkins AJ, Rowley KG, Lyons TJ, Best JD, Hill MA, Klein RL. Lipoproteins and diabetic microvascular complications. Curr Pharm Des 2004;10:3395–3418
   PubMed Web of Science ®Google Scholar
• Wu L, Hernandez-Bogantes E, Roca JA, Arevalo JF, Barraza K, Lasave AF. Intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic maculopathy: a pilot study from the Pan-American Collaborative Retina Study Group. Retina 2011;31:298–303
   PubMed Web of Science ®Google Scholar
• Reddy GB, Satyanarayana A, Balakrishna N, Ayyagari R, Padma M, Viswanath K, et al. Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy. Mol Vis 2008;14:593–601
   PubMed Web of Science ®Google Scholar
• Mao R, Fan Y, Chen F, Fu S. Genetic polymorphism of MTHFR G1793A in Chinese populations. Eur J Epidemiol 2008;23:363–368
   PubMedGoogle Scholar
• Chan E, Fonseca VA. Management of hyperhomocysteinemia. Metab Syndr Relat Disord 2003;1:159–170
   PubMedGoogle Scholar
• House AA, Eliasziw M, Cattran DC, Churchill DN, Oliver MJ, Fine A, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 2010;303:1603–1609
   PubMed Web of Science ®Google Scholar
• Sun Y, Lai MS, Lu CJ. Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials. Acta Neurol Taiwan 2005;14:48–54
   PubMedGoogle Scholar